CTOs on the Move

Concert Pharmaceuticals

www.concertpharma.com

 
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Funding

Concert Pharmaceuticals raised $30M on 06/12/2017
Concert Pharmaceuticals raised $66.4M on 06/01/2022

Similar Companies

TYRX

TYRX is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Navitas Pharma

Navitas Pharma is a Laramie, WY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Michael's Pharmacy

Michael's Pharmacy is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Academic Psychiatry

Academic Psychiatry is a Arlington, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lakemary

Founded in 1969, Lakemary is in America’s Heartland. Our main campus and ranch are on 32 acres in the quiet town of Paola, KS just south of Kansas City. Our...